home All News open_in_new Full Article

AstraZeneca pens $630M pact to secure remaining rights to armored CAR

AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta  Fierce Biotech


today 16 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Society
attach_file Society
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics


ID: 2103593786
Add Watch Country

arrow_drop_down